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Abstract  
Soy protein isolate (SPI) is the purest form of protein from soybean with minimum protein 
content of 90%. Due to its high protein content, SPI is commonly used in food processing 
for improving the quality of food products, including infant formula. The use of SPI in infant 
formula is mainly designed for infant who cannot tolerate cow’s milk-based formula. This 
report reviews the benefit of using SPI in soy-based infant formula rather than soymilk 
from whole soybean itself. It will also review the technology of soy protein isolation which 
can result SPI for high quality infant formula, including the reducing of unfavourable 
ingredients which will ensure the safety of soy protein-based infant formula. 
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Introduction 
Soybeans, which are leguminous crops belonging to 
the family Fabaceae, have served as a valuable 
source of food which contain a nutrient source. This 
plant product has been widely used in a variety of 
food products. Applications of soybeans in food 
products are presented in a variety of forms, 
including infant formulas, cheese, drinks, miso, 
tempeh, tofu, salami, and vegetarian meat 
substitutes.1  
Commonly, soybean derived products, such as 
soy protein has received growing an attention due to 
its chemical composition, functional properties, and 
multiple applications in food industry. According to 
Codex Standard,2 soy protein products are classified 
based on their dry base protein contents, namely soy 
flour (40–50% of protein), soy protein concentrates 
(70 – < 90% of protein), and soy protein isolate 
(≥90% of protein).  
Each type of soy protein has different 
application in products according to their functional 
properties (Table 1). Soy protein has a good supply 
of essential amino acids compared with other plant 
proteins. Soy protein has high lysine, which is 
normally lacking in other cereal, but low in cysteine 
and methionine. Due to its high protein content 
(~90%), soy protein isolate is considered as one of 
raw material in producing soy-based infant formula. 
 
Soy Protein Isolate vs Soy Milk 
 
Soy protein isolate (SPI) is the purest form of protein 
in soybean with minimum protein content of 90% 
(dry basis), which is obtained by extracting the 
soluble protein and removing non-protein material 
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such as fat and carbohydrates. Because of this 
process, it has a neutral flavour and cause less 
flatulence than soy flours.  
Soymilk is a milky liquid made from whole 
soybean or full-fat soy flour. Its composition and 
nutrient are similar to those of dairy milk.4 Soymilk 
processing is including soaking soybean in water, 
filtering the soybean slurry with gauze, and heating 
the obtained filtrate by sterilization. According to 
its processing, it showed that soy milk still contains 
more non-protein content compared to SPI. 
Furthermore, SPI has higher Protein 
Digestibility Corrected Amino Acid Score 
(PDCAAS) compared to soymilk, which is 100% 
and 92.6% respectively.5 It shows that PDCAAS of 
SPI is equivalent to animal proteins quality, 
suggested that SPI is essential as alternative protein 
source to support growth of infant. 
Infant formula is designed to be a supplement 
to breast milk, and may be also used as a substitute 
if breastfeeding is feasible, which is made by mixing 
proteins, fats, carbohydrates, minerals, and vitamin 
components. The mixture is then blended, 
pasteurized, homogenized, and condensed, then 
either spray-dried (powder-base) or sterilized 
(drink-base).6  
Soy-based infant formula is designed as a 
suitable alternative for infant with intolerance to 
lactose and cow’s milk proteins. Lactose intolerance 
occurs when small intestine fails to produce 
sufficient amount of lactase enzyme. Lactase 
enzyme is released in normal infant’s digestive 
system in order to digest milk, including breast milk, 
whether premature infants sometimes fail to produce 
enough lactase.7 
 
Benefit Use of SPI in Market 
 
Soy protein products, especially SPI have been used 
as food ingredients in wide category due to their 
nutritional and functional properties. Moreover, 
soybean is a low-cost vegetable sources of protein, 
which cause soy protein products offer more than 
just obvious economic advantages that vegetable 
proteins have over animal proteins. Soybean 
processing into soy protein has resulted in products 
that can be used for many functions in foods, such 
as emulsification, binding, and texture.8 The 
excellent nutritional value of soy protein has been 
recognized by Food and Drug Administration 
(FDA) and the United States Department of 
Agriculture’s (USDA) School Lunch Program. 
One of SPI use in the market is as the protein 
main source in infant formula. Soy-protein based 
infant formulas in the United States are nearly 25% 
of the formula market, 13% in New Zealand, 7% in 
the United Kingdom, 5% in Italy, and 2% in France, 
which use SPI as their main ingredients.9,10 In the 
beginning of their launching into the U.S. market in 
1950, soy-based infant formulas were using soy 
flour as their raw material. The formulas were tan in 
color and had a nutty odor. Then, in the 1960s, soy-
based infant formulas came up with SPI, and within 
10 years almost completely replaced soy flour-based 
infant formula in the U.S. Those formulas are only 
Table 1. Application of soy protein in food products 
 
Functional properties Soy forms Food Application 
Fat absorption F, C, I Frankfurters, meat burgers, 
sausage, donuts, bologna 
   
Water absorption F, C Confections, breads, cakes 
   
Emulsification F, C, I Frankfurters, sausage, bologna, 
cakes, and breads 
   
Solubility F, C, I Beverages 
   
Gelation C, I Meat, curd, cheese 
   
Elasticity  I Baked goods, simulated goods 
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darker than milk-based formulas and nearly 
odourless.11  
Not only benefit for their appearance, SPI also 
have lower phytate content because of precipitation 
method in obtaining protein isolates. The method 
resulting the increase of absorption and availability 
of zinc and copper in infant rhesus monkeys and rat 
pups due to the reduction of the phytate content of 
soy formula by using SPI.12 
 
Food Technology of SPI and Impact on 
Unfavourable Ingredient 
 
The general methods of soy protein isolation are 
using aqueous extraction process (isoelectric 
precipitation principal) and membrane ultrafiltration 
process. Aqueous extraction technique is based on 
the solubility of protein at different pHs. Basically, 
SPI are produced by extracting the soy flakes in 
alkali condition (pH 8 – 9) with subsequent 
centrifugation to produce a soy protein extract 
containing soluble protein, oligosaccharides, and 
minerals. Acidification of the obtained extract to pH 
4.5 (isoelectric point) will precipitate the proteins 
into a curd. Subsequent washing of the curd will 
remove soluble non-protein component. The 
following neutralization at pH 7 and drying finally 
will result SPI3.  
Whether ultrafiltration membrane is using 
membrane isolation technique. Different from 
aqueous extraction, membrane isolation recovers 
protein directly from soybean flour extracts and thus 
avoid the generation of whey protein from acid-
precipitation, which results higher protein isolate 
yield, since one-third of soy whey proteins are very 
hard to recover.13 According to Codex Standard,2 
maximum water content, ash content, and crude 
fiber of SPI is 10, 8, and 0.05% respectively, with 
minimum protein content of 90%. 
Soybeans naturally had anti-nutritional factors 
such as phytic acid, trypsin and other enzyme 
inhibitors, lectin, and phenolic compounds, which 
can cause undesirable effects on digestion and 
absorption of nutrition. Results found that SPI with 
ultrafiltration process had low phytic acid content, 
improved digestibility, high water solubility, 
improved functional properties, and absence of 
beany flavour with high palatability and nutrition 
due to the removal of oligosaccharides and minerals 
which are permeate through the membrane.14  
Removal of phytic acid in SPI can improve 
digestibility of minerals such as calcium, therefore 
manufactures do not need to enrich their soymilk 
products with calcium carbonate to ensure adequate 
adsorption. Soybean also contains isoflavones 
(phytoestrogen) which have been of particular 
interest due to their effects on sexual development 
and reproduction. Approximately, 30% of the total 
isoflavones are lost in the insoluble fraction during 
SPI production.15 Another study also showed that 
soymilk which was made from SPI had lower 
isoflavones content compared to soymilk from 
whole soybean due to loss of isoflavones occurs 
during the separation of isolated protein.16  
Numerous studies showed that dietary 
isoflavones in soy-based infant formula do not 
adversely affect human growth, development, or 
reproduction.17 Setchell et al.18 reported that no 
clinical symptoms, growth, or development adverse 
effects related to plasma concentration of 
isoflavones in soy-fed infants. Furthermore, there 
was also no reported adverse estrogenic effects on 
sexual development in infants fed soy-based infant 
formula.  
Businco et al.19 also reported that 
phytoestrogens in soy-based infant formula did not 
induce hormonal effects in 34 young adults who had 
been fed soy-based infant formula when they were 
toddlers. Strom et al.20 also found no statistically 
significant differences in general health and 
development between groups who had soy-based 
infant formula and groups who had milk-based 
infant formula during their first 4 months, in either 
females or males. It showed that sexual development 
and maturation of infants fed soy-based infant 
formula are normal. 
Soymilk has not gained popularity compared 
to cow’s milk due to its off-flavour and only used as 
a milk substitute by a group of people who cannot 
tolerate cow’s milk. The off-flavour (beany/grassy, 
bitter, and astringent flavour) of soymilk was from 
soybean, which was as a result of lipid oxidation, 
lipoxygenase activity, polar lipids, bitter peptide and 
lipids21. Soybean defatting and protein extraction 
could have a significant impact on the taste and 
flavour of SPI and thus on the finished food products 
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due to the removal of lipids in soy flakes which are 
the major substrate of lipoxygenase3. 
Besides, the presence of allergenicity in SPI 
could be removed by using HHP (High Hydrostatic 
Pressure) processing. HHP treatment could 
significantly influence the free SH (Sulfhydryl) 
content and hydrophobicity of SPI, which are 
closely associated with the allergenicity of SPI. HHP 
would influence that interaction and interfere with 
the structure of soy allergen epitopes, thus reducing 
the allergenicity of SPI. HHP treatment at 300 MPa 
and 15 min could decrease allergenicity up to 48.6% 
compared to native SPI.22 
 
Food Processing to Ensure High Quality of SPI 
Formula for Children 
 
Infant formula is designed for use as a substitute for 
human milk when breastfeeding is unable, then there 
should be a processing technology to achieve 
nutrient similarity to human milk. Ingredients added 
to soy-based infant formula are SPI, which utilize as 
the main protein source, and supplemented with L-
methionine, carnitine, and taurine.  
SPI is added to achieve protein content 
ranging 2.45–2.8 g per 100 kcal. Besides, soy-based 
infant formula does not contain lactose, it needs 
addition of corn maltodextrin, corn syrup solids, and 
sucrose as replacers for carbohydrates then to 
provide carbohydrate content of 10.26–10.95 g per 
100 kcal.23,9 Furthermore, addition of lipids is also 
needed, which content ranges from 5.02–5.46 g per 
100 kcal, since lipids are predominant source of 
energy, required for absorption of fat-soluble 
vitamins, carotenoids, cholesterol, and contribute to 
flavours and satiety. Fat blends of soy oil and 
coconut oil with proportions 40% and 60% 
respectively, which have higher absorption of fat 
and mineral compared to mixture of palm oil and soy 
oil.  
Soy-based infant formula also needs to be 
fortified with iron as a way of reducing the 
prevalence of anemia. Moreover, vitamin such as 
vitamin D3, vitamin K, vitamin B12 also found in 
many fortified infant formula.9,24 
Infant formulas are commonly sold in 
powdered form. Powdered infant formula is 
generally manufactured using one of two types of 
process, namely dry blending process or wet mixing-
spray drying. Briefly, dry blending process is 
process of combining all of the dry ingredients 
which previously have been prepared individually 
(heat-treated) to finally dry-blended, whether wet 
mixing-spray process is using all ingredients in a 
liquid phase and heat-treating 
(pasteurization/sterilization) to finally dry-sprayed. 
Each process has its own advantages and 
disadvantages.  
The advantages of using the dry blending 
process are using less energy and having the less risk 
of microbiological contamination because the water 
is not involved in this process, but the disadvantages 
are no heat treatment to destroy bacteria in the final 
product. Furthermore, the different ingredients will 
segregate during transportation and storage due to 
their varied densities, resulting in inhomogeneous 
state for the consumer.25  
The wet mixing-spray process currently 
remains the most widely used method of producing 
powdered infant formula.23 The advantage of this 
process is all quality aspects can be more effectively 
controlled than dry mixing process, resulting 
improved quality powder including microbiological, 
physical, and chemical properties, whether its 
disadvantage is using more energy and time 
compared to dry mixing process.25 
   
Concern of GM and Non-GM Soybean 
 
Genetically-modified (GM) organisms are crop 
plants that using the latest molecular biology 
techniques and have been modified to enhance some 
desired traits. Soybean is one of the examples of 
GMO results. This kind of soybeans is herbicide 
Roundup® (glyphosate)-resistant, that will reduce 
the production cost and limit the dangers of 
agricultural waste run-off.  
In the U.S., the cultivation of GM soybeans 
was increasing every year. In 1996, approximately 
7% of all soybeans cultivated were GMO, up to 42% 
in 1998, and increased to 54% of all soybeans in 
2000.26 But, GMO still has concerns related to 
human health risks and long-term effects on human 
beings. Many people prefer to stay away from GMO 
because of the transfer of antibiotic resistance, 
toxicity, and allergenicity possibility due to the 
presence of transgenes that have been inserted into 
the crops. Because of these issues, labelling of GM 
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foods is required by EU legislation, as a tool for the 
first-time consumer to get well-informed.27 
However, several studies showed no meaningful 
effects and differences from GM soybeans 
compared to non-GM soybeans. Netherwood et al.28 
reported no gene transfer occur during GM soy fed 
in seven human volunteers’ gut because the 
transgene did not survive passage through intact 
gastrointestinal tract.  
Another study also found no biologically 
significant differences occur in the in vivo 
nutritional response of body weight, body weight 
gain, and food consumption of rats compared to the 
non-GM soybeans in the diet. That indicate both 
soybeans were nutritionally equivalent, providing 
evidence that GM soybeans did not have cause 
unintended deleterious nutritional changes. 
Furthermore, no significant differences in MDA 
(Malondialdehyde) and PC (Protein Carbonyl) 
levels of rats were found, indicate no differences in 
lipid peroxidation and protein oxidation levels.29,30 
 
Conclusion 
Soy protein isolate (SPI) has been widely used due 
to its chemical composition, functional properties, 
and multiple applications in food industry, including 
soy-based infant formula, which is mainly designed 
for infant who cannot tolerate cow’s milk-based 
formula. The use of SPI can be beneficial for infant 
formula by resulting better appearance and flavor, 
lower phytate content, higher protein digestibility, 
and higher mineral absorption and availability due 
to protein isolation process with ultrafiltration 
method, compared to soy-based infant formula using 
soybean itself. Furthermore, presence of 
allergenicity in SPI also could be removed by using 
HHP (High Hydrostatic Pressure) processing. 
Several studies related to particular interests in 
soybean such as isoflavone and GMO issues also 
reported no meaningful adverse effects, which 
indicate SPI is safe for used as raw material for 
infant formula production. 
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